Seviol Tablet 5/40 mg
Amlodipine Besylate · Olmesartan Medoxomil
Prescription medication · Combination
Jungheon Pharmaceutical Co., Ltd.
MFDS item code 201803058 · Approved 2018.07.24
This product's status changed to Expired on 2023.07.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
Amlodipine or Olmesartan Medoxomil is used when blood pressure control is not adequately achieved in patients with essential hypertension. These medications lower blood pressure by either dilating blood vessels or regulating blood pressure. They can effectively help stabilize blood pressure, particularly when monotherapy does not sufficiently control blood pressure. This can reduce the risk of cardiovascular complications due to hypertension. Hence, they are used to improve blood pressure in the treatment of essential hypertension.
Take 1 tablet once daily with water, regardless of meals. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40 mg. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The recommended doses are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or olmesartan medoxomil 20 mg monotherapy. - 10/20 mg: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 mg monotherapy. - 5/40 mg: For patients whose blood pressure is not adequately controlled with 5/20 mg. - 10/40 mg: For patients whose blood pressure is not adequately controlled with 5/40 mg. ∘Patients with renal impairment: This medicine has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 mg once daily. Use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with intravascular volume depletion: In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 mg once daily, and the maximum dose is 20 mg once daily. Patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics should be closely monitored for blood pressure and renal function. This medicine should not be administered to patients with severe hepatic impairment. (See section 2. Patients who should not receive this medicine under Precautions for Use.) ∘Elderly patients: Treatment should generally be initiated at a low dose. When adjusting the dose, the patient's renal or cardiac function and comorbidities should be taken into consideration. Blood pressure should be monitored closely and more frequently in elderly patients.
∘Children: The safety and efficacy in pediatric patients under 18 years of age have not been established.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be stopped immediately if pregnancy is confirmed. It should not be used in patients with known allergies to this drug's active ingredients or similar classes of drugs, pregnant or breastfeeding women, patients with severe liver impairment or specific heart diseases, and patients undergoing kidney dialysis. Patients with insufficient body fluid or sodium should be closely monitored as initial dosing may cause excessively low blood pressure, and appropriate measures should be taken if blood pressure drops too low. Due to its vasodilatory effects, caution is advised when using this medication in patients with specific heart diseases. Patients with weak kidney function or liver impairment should be cautious as this medication may affect the kidneys and liver. Side effects such as dizziness, headache, low blood pressure, indigestion, skin rash may occur during the use of this medication, and if any abnormal symptoms develop, it is advised to consult a physician. Particular attention is necessary if this medication is taken alongside potassium supplements or other antihypertensive medications as blood pressure may drop too low or potassium levels in the blood may rise. This medication should not be used during pregnancy, and it is advisable to switch to a different safe antihypertensive medication if planning to become pregnant. During breastfeeding, this medication may be transferred to breast milk and could affect the baby, so the decision to take it should be made carefully. Safety and efficacy in children under 18 years of age have not been established, therefore it is not recommended. In the elderly, where functions of the liver, kidneys, and heart may be diminished, dosage adjustments should be made with caution. In case of overdose, blood pressure may drop too low, and heart rate may increase, necessitating immediate medical attention. This medication should be stored in a cool, dry place away from direct sunlight and moisture, and should be kept out of reach of children. It is advisable to avoid transferring it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is best to maintain the storage temperature between 1°C to 30°C (room temperature). Proper storage helps to maintain the medication's effectiveness and safety over time.
Pale yellow round film-coated tablet
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate · Olmesartan Medoxomil
Prescription medication · Combination
Jungheon Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.